Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citicoline for Newborns with Hypoxic Ischemic Encephalopathy
NCT03181646Phase 3Unknown
- Sponsor
- Combined Military Hospital
- Start
- Jun 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of citicoline in hypoxic-ischemic encephalopathy (HIE), sponsored by Combined Military Hospital. Status: unknown.
02
Drugs
citicoline
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT03181646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03181646.